FOXP3 and cancer: Moreover, the level of CTLA-4 expression on Foxp3+CD4+ Tregs (as evaluated by median fluorescence intensity) progressively increased in cancer patients after the initiation of radiotherapy, reaching significantly higher levels 24 and 36 months after seed implantation compared to both healthy controls and cancer patients before treatment (Figure 3E).